Does Weed Raise Blood Pressure? What Research Shows

Search this question and you will find confident answers in both directions. Some sources say cannabis raises blood pressure. Others say it lowers it. Both are describing something real, and the disagreement dissolves once you ask a more precise question: raises it when, measured how, and in whom.

Does Weed Raise Blood Pressure?

Yes, slightly, while you are lying down, and not for long.

The consistent finding across the cardiovascular literature is that cannabis smoking produces a slight increase in supine blood pressure, meaning blood pressure measured while lying down. That increase travels alongside a much larger effect on heart rate, which is the change clinicians actually watch.

At higher doses the direction can reverse when you change posture. Cannabis can produce postural hypotension, a drop in blood pressure on standing that presents as dizziness or fainting, because vascular resistance decreases. So a person who reports that cannabis lowered their blood pressure and a person who reports that it raised theirs may both be reporting accurately, having measured at different moments in different positions.

The American Heart Association scientific statement on cannabis and cardiovascular health summarizes the mechanism: THC stimulates the sympathetic nervous system while inhibiting the parasympathetic nervous system, which increases heart rate, myocardial oxygen demand, and supine blood pressure.

The Heart Rate Effect Is Larger and Better Documented

If you are asking about blood pressure because you are worried about your heart, heart rate is the more useful number.

One of the most consistent effects of cannabis smoking is a 20 to 100 percent increase in heart rate, which can last two to three hours. The mechanism is generally described as cannabis-induced vasodilation producing a reflex tachycardia. That is a large swing relative to the modest blood pressure change accompanying it.

Increased heart rate matters clinically for a specific reason: it raises myocardial oxygen demand, the amount of oxygen the heart muscle requires. In a healthy person with clear coronary arteries that demand is met without difficulty. In a person with existing coronary disease, an abrupt increase in demand is the same physiology that underlies exertional angina.

The American Heart Association statement also records short-term associations with tachycardia, premature ventricular contractions, atrial fibrillation, and ventricular arrhythmia. Those are associations reported in the literature rather than established causal effects, and they are the reason cardiology guidance emphasizes screening for cannabis use rather than treating it as clinically silent.

What Happens With Regular Use

Here the picture changes substantially, and this is where most short answers go wrong.

Tolerance to the cardiovascular effects develops rapidly, after only a day or two of repeated exposure. With chronic use the adaptations are consistent and documented:

• Heart rate decreases
• Orthostatic hypotension disappears
• Blood volume increases
• Circulatory responses to exercise are diminished

Those changes are consistent with reduced sympathetic and enhanced parasympathetic activity. A daily user and a first-time user are, physiologically, answering two different questions when asked whether cannabis affects their blood pressure.

There is an important limit on what that tolerance means. Tolerance to an acute effect is not evidence that longer-term risk disappears. The acute studies measure blood pressure and heart rate over hours. The outcome studies below measure heart attacks and strokes over years. They are different measurements, and the second set does not become reassuring because the first set attenuates.

What the Outcome Research Shows

Four bodies of evidence bear on whether any of this translates into events that matter.

The 2001 case-crossover study interviewed 3,882 patients after acute myocardial infarction. Of those, 124 reported smoking cannabis in the prior year, 37 within 24 hours, and 9 within the hour before symptoms began. Comparing each patient against their own usual pattern, risk in the hour after use was elevated 4.8-fold. The absolute number of exposed cases is small, which is worth holding in mind alongside the size of the ratio.

The 2024 cardiovascular outcomes study drew on 434,104 adults from the Behavioral Risk Factor Surveillance Survey across 2016 to 2020, adjusting for tobacco use. For daily cannabis use the adjusted odds ratios were:

• Myocardial infarction 1.25 (95% CI 1.07 to 1.46)
• Stroke 1.42 (95% CI 1.20 to 1.68)
• Composite of all three outcomes 1.28 (95% CI 1.13 to 1.44)
• Coronary heart disease 1.16 (95% CI 0.98 to 1.38), not statistically significant

Among adults who had never smoked tobacco, the associations were larger: myocardial infarction 1.49 and stroke 2.16. That subgroup matters because it addresses the most obvious confounder, which is that cannabis smokers are more likely to be tobacco smokers.

A 2025 meta-analysis in Heart pooled 24 studies and reported a relative risk of 2.10 for cardiovascular death, 1.29 for acute coronary syndromes, and 1.20 for stroke.

Why These Numbers Deserve Caution

None of the outcome research establishes that cannabis causes cardiovascular events, and the authors say so directly.

The 2024 study is cross-sectional, which means exposure and outcome were measured at the same moment. It cannot establish that use preceded the event. Its authors note they could not exclude reverse causality, that cannabis use was self-reported, and that the survey lacked baseline lipid profiles and blood pressure measurements.

The 2025 meta-analysis pooled mostly cross-sectional studies and reported that there was no standardized approach to measuring cannabis exposure across them. It could not determine whether events occurred during active use, could not separate smoked from edible forms, and could not account for potency.

Route of administration is probably the largest unresolved question. In the 2024 study, 73.8 percent of current users reported smoking as their method. Findings that describe smoked cannabis include the effects of combustion products, which is not the same exposure as an oral or sublingual product.

What the evidence supports is a consistent association across independent designs, in a direction that matches the known acute physiology. What it does not support is a precise risk figure for any individual patient.

Is High Blood Pressure a Qualifying Condition?

No. Hypertension is not a listed qualifying condition in Florida, Georgia, or Texas.

This follows from the evidence rather than from an administrative oversight. The American Heart Association statement concluded that it identified no cardiovascular benefits from cannabis use. A state program listing hypertension would be listing a condition the cardiovascular literature does not support treating this way.

If you are researching this question because you have high blood pressure and are considering certification for a different condition, that is a reasonable thing to raise at the appointment. The qualifying conditions page covers the Florida list, and the eligibility table on each condition page shows whether that condition is listed in Florida, Georgia, and Texas.

What This Means for Florida, Georgia, and Texas Patients

Tell the physician about cardiovascular history. Existing coronary disease, arrhythmia, prior heart attack or stroke, and current antihypertensive medication all belong in the conversation. Cardiology guidance emphasizes that providers be aware of the potential for cannabis to precipitate cardiovascular events in patients with pre-existing disease, and that awareness depends on the patient disclosing it.

Expect the route of administration to come up. The strongest outcome signals come from populations that predominantly smoked. That is a reason to discuss non-combusted options rather than a reason to assume they carry identical risk, because the research has not separated them cleanly.

Do not read tolerance as safety. The acute heart rate and blood pressure effects attenuate within days of regular use. The outcome studies looked at daily users specifically and still found elevated associations.

Be careful in the first hours after use if you are new to it. Postural hypotension and the 20 to 100 percent heart rate increase are most pronounced before tolerance develops. Standing up quickly is the practical scenario in which that matters.

Sources for Cannabis and Cardiovascular Effects

• Medical Marijuana, Recreational Cannabis, and Cardiovascular Health, American Heart Association. Page RL 2nd et al. Scientific statement, Circulation 2020;142:e131 to e152. Covers THC autonomic mechanism, heart rate, myocardial oxygen demand, supine blood pressure, and short-term arrhythmia associations.
• Triggering Myocardial Infarction by Marijuana. Mittleman MA, Lewis RA, Maclure M, et al. Circulation 2001. Case-crossover analysis of 3,882 patients from the Determinants of Myocardial Infarction Onset Study.
• Association of Cannabis Use With Cardiovascular Outcomes Among US Adults. Jeffers AM et al. Journal of the American Heart Association 2024. 434,104 adults, Behavioral Risk Factor Surveillance Survey 2016 to 2020.
• Role of cannabis in cardiovascular disorders. Goyal H et al. Journal of Thoracic Disease. Review covering the acute heart rate response, postural hypotension mechanism, and tolerance adaptations with chronic use.
• Cardiovascular Risk of Marijuana, American College of Cardiology. Clinical commentary on mechanism and on screening patients with pre-existing cardiovascular disease.
• Storck W, Elbaz M, Vindis C, et al. Heart 2025. Meta-analysis of 24 studies reporting pooled relative risks for cardiovascular death, acute coronary syndromes, and stroke, with stated limits on exposure measurement, route, and potency.

Related Health and Eligibility Resources

• The is weed a depressant, stimulant, or hallucinogen post covers why the heart rate response above is the strongest evidence for the stimulant side of a drug that also produces depressant effects.
• The health benefits of medical cannabis post covers the conditions where the evidence base is strongest.
• The qualifying conditions page covers eligibility across all three state programs.
• The chronic pain, cancer, and PTSD condition pages cover the listed conditions patients most often ask about alongside cardiovascular history.
• The Florida marijuana laws, Georgia marijuana laws, and Texas marijuana laws pages cover each state program and its condition list.

Talk to a Physician About Your Cardiovascular History

Miracle Leaf® physicians evaluate patients for state medical cannabis programs in Florida, Georgia, and Texas. If you have a cardiac history, take blood pressure medication, or have been told to watch your heart rate, raise it at the appointment. It changes the evaluation, and in some cases it changes the recommendation.

Call (833) LEGAL-MJ or contact us online to book. Evaluation pricing is on the pricing page.

Disclaimer

This post is informational and is not medical advice. The figures cited are drawn from published research populations and do not predict outcomes for any individual. The outcome studies described here are observational and cannot establish that cannabis use causes cardiovascular events. The 2024 cardiovascular outcomes study is cross-sectional and relied on self-reported use, and the 2025 meta-analysis pooled studies with no standardized measure of cannabis exposure. Neither separated smoked from non-combusted routes. Hypertension is not a qualifying condition in Florida, Georgia, or Texas. Consult a licensed physician about cannabis use in the context of your own cardiovascular history, and do not stop or change a prescribed medication based on this article.